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Stigma and Therapy Completion for Latent
Tuberculosis among Haitian-origin Patients
Jeannine Coreil, PhD, Michael Lauzardo, MD, Heather Clayton, MPH
ABSTRACT
A prospective cohort study of LTBI treatment conducted within the Haitian population of South Florida investigated
the predictive association between illness-related stigma among patients near the beginning of treatment and
completion of preventive therapy. Factors associated with perceived stigma were also investigated. Ninety patients
from Broward and Palm Beach counties were administered a questionnaire that included items related to illness
history, perceptions and understanding of latent tuberculosis, and a 25-item stigma scale adapted from previously
developed measures of tuberculosis-related stigma. Therapy completion was determined through a follow-up chart
review. Data analyses compared patients who completed therapy with those who defaulted on a number of variables
including perceived stigma. No association was found between perceived stigma or demographic characteristics
and adherence to preventive therapy. Perceived stigma was associated with patient report of illness-related distress
and was higher among patients who were lost to follow up. Some evidence suggested that stigma was higher among
contacts of cases, patients with limited understanding of the condition, and patients who were more closely
monitored during treatment. Case management should focus on patient-centered approaches to education and
counseling about LTBI that address patient understanding of the condition and concerns about its physical and
psychosocial effects.
Florida Public Health Review, 2010; 7, 32-38.
Introduction
This study investigated the predictive association
between tuberculosis-related stigma and completion
of preventive therapy for latent tuberculosis infection
(LTBI). We tested the hypothesis that perceived
stigma is negatively associated with adherence to
LTBI treatment through a cohort study of latent TB
patients of Haitian origin in Florida.
Completion rates for treatment of LTBI are
consistently low across diverse populations (Bieberly
& Ali, 2008; Hirsch-Moverman, Daftary, Franks, &
Colson, 2008; Pina-Gutierrez, Ferrer-Traid, Arias,
Sala-Farre, & Lopez-Sanmartin, 2008). A recent
review of 78 studies found inconsistent associations
between adherence and patient factors, clinic
facilities, treatment characteristics and interventions
to increase adherence (Hirsch-Moverman, et al.,
2008). Researchers have suggested that social stigma
may deter therapy completion among active
tuberculosis patients (Macq, Solis, & Martinez,
2006), however we found no published studies that
investigated stigma related to LTBI or the influence
of patient-perceived stigma on completion of therapy.
In recent years public health attention to
tuberculosis has been increasingly focused on
immigrant groups that are disproportionately affected
by the disease (Cain, Benoit, Winston, & MacKenzie,
2008). In South Florida, Haiti is the most common
birth country (34.3%) among immigrants diagnosed
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with TB (Talbot, Moore, McCray, & Binkin, 2000).
Between 1993 and 1998, the case rate for active
tuberculosis among Haitians living in the U.S. was
118.5 per 100,000 persons per year (Talbot, Moore,
McCray, & Binkin (2000). Haitians make up only 2%
of the state’s population, but accounted for 15% of all
active cases of TB during the time of our study. A
retrospective chart and database review in 2000 of
reported cases of LTBI in Haitians living in Florida
found 38% of Haitians completed therapy, compared
to a 60% completion rate for all others on therapy for
LTBI (Lauzardo, Duncan, Szwed, Narita, & Hale,
2001).
The potential for TB-related stigma to be of
concern within the Haitian population is noteworthy
because of deeply-rooted prejudice and negative
stereotypes of the Haitian population in American
society (Farmer, 1992; Granich et al., 1998;
Nachman, 1993). The legacy of labeling Haitians as a
risk group for HIV/AIDS in the 1980s continues to
negatively impact public perceptions as well as
within-group perceptions of community attitudes
towards this population (Coreil, Lauzardo, &
Heurtelou, 2004; Stepick, 1998). Moreover, the
resurgence of TB in recent years is associated with
the AIDS epidemic. For these reasons, strong
perceptions of stigma related to tuberculosis would
be expected in this population.
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Study Population and Methods
The adherence cohort study conducted in Florida
was part of a larger cultural epidemiologic study of
stigma and tuberculosis in Haitian populations
residing in Haiti and the USA. Patients were adults
diagnosed with latent TB infection (PPD+ skin test,
but x-ray negative and asymptomatic) who began
preventive therapy through the Broward County
Health Department or the Palm Beach County Health
Department.
In Florida, passive surveillance
programs for TB are in place at public clinics that
serve high-risk groups. Screening is offered to
Haitians, other foreign born individuals, and others
with risk factors for progressing to active disease
who access all health department clinics and services,
and approximately half of patients offered the
treatment accept to begin therapy.
First line
recommended therapy is daily doses of isoniazid
(INH) for a period of 9 months, if there are no
contraindications.
Ethical oversight of the study was reviewed by
the Institutional Review Boards of the University of
South Florida, the University of Florida and the
Florida Department of Health. All study participants
gave informed consent to take part in the study.
A total of 90 patients were enrolled in the
adherence study over a two year period (August
2005-July 2007), 63 from Broward County and 27
from
Palm
Beach
County.
Demographic
characteristics of the sample are presented in Table 2.
The primary outcome measure of adherence was
completion of therapy. Adherence to the prescribed
therapeutic regimen is monitored through monthly
follow-up appointments where patients come in for a
check-up and to receive a month’s supply of
medication. High risk patients, including children
and HIV co-infected persons, are monitored through
directly observed preventive therapy (DOPT).
Follow-up data on treatment completion were
extracted from patient records. Treatment adherence
was measured by a dichotomous variable (complete
vs. default) and analyzed in relation to several
independent variables including stigma score,
accurate understanding of the condition, perceived
cause, reported distress, participation in DOPT,
county of residence and socio-demographic variables.
Study variables were measured through an
interviewer-administered questionnaire called the
EMIC for Tuberculosis in Haitian Populations,
adapted from a similar instrument developed for a
multi-country study of tuberculosis and gender
(Weiss et al., 2008). Development of the stigma scale
began with a core set of items used in previous
studies of stigma, including items related to internal
perceptions and emotions, disclosure,
external
perceptions, external actions, and courtesy stigma
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(effects on significant others). Based on local
validation procedures and previous ethnographic
research (Coreil, Lauzardo, & Heurtelou, 2004), two
items were added to the scale related to patients
feeling greater stigma because they were Haitian. Out
of 34 items in the stigma scale, 9 were deleted
because they showed weak correlations with the other
items in the scale. The final scale (Table 1) consisted
of 25 items with good internal consistency (α = .87).
Coding of responses for the Stigma Scale ranges
from 0-3 (0 for “no,” 1 for “uncertain,” 2 for
“possibly,” and 3 for “yes”). A composite stigma
score is computed by adding scores for each item.
Results
Overall level of perceived stigma was low, with
a mean score of 25.1 for the total patient sample
(maximum possible score of 100). The majority of
patients responded “No” to most scale items, with the
exception of items related to disclosure of one’s
diagnosis to others. Most participants (76-92%)
indicated they would not discuss their condition with
people outside the family (friends, neighbors, coworkers, church members, others), and about half
(51%) would not discuss it with family members
Of the 90 LTBI patients, 67 (74.4%) had chartdocumented completion of therapy, 5 (5.5%)
discontinued therapy because of medical advice, and
18 (20.0%) were categorized as “defaulters.” Within
the defaulter group, 5 had chart-documented
voluntary withdrawal from therapy and 13 were
considered “lost to follow-up” because they moved,
could not be located, or no information was found in
their charts regarding completion. No significant
differences in therapy completion rates were found
by county, socio-demographic characteristics, referral
source, participation in DOPT, perceived cause or
patient understanding of the condition. However, it
is noteworthy that only the HIV co-infection group,
all of which received DOPT, had 100% completion
rates. No significant differences in mean stigma
scores were found across therapy completion groups,
categorized various ways. Likewise, no group
differences were found when individual items in the
stigma scale were analyzed separately.
Comparison of stigma scores between the
treatment completion group and the defaulter group
showed they were almost identical (24.9, 25.0).
However when defaulters in the “moved or lost to
follow-up” group (N = 6) were compared to other
defaulters, significant differences in stigma scores
were found. The “moved or lost to follow-up” group
had a mean stigma score of 36.3 compared to a mean
score of 21.6 for other defaulters (t = 2.65, df = 21, p
= .015).
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Table 1. Stigma Scale Items
Internal Perceptions and Emotions
1. Do you think less of yourself because of this problem? Has it reduced your pride or self-respect?
2. Have you ever been made to feel shamed or embarrassed because of this problem, or are you concerned that
this might happen?
Disclosure
3. If possible, would you prefer to keep people from knowing about this problem?
4. Have you discussed or do you plan to discuss this problem with the person you consider closest to you, the
one whom you usually feel you can talk to the most easily?
5. Have you discussed or do you plan to discuss this with neighbors?
6. Have you discussed or do you plan to discuss this with co-workers?
External Perceptions
7. Do your neighbors, colleagues or others in your community have less respect for you because of this
problem, or do you think they would if they knew about it?
8. If they knew about it, would your neighbors, colleagues or others in your community think less of your
family because of this problem?
9. Even if you don’t (or didn’t) have any other health problems, are people likely to think you do because of
your TB germ/disease?
10. Are you worried that people will assume you have HIV?
11. Are you concerned that others will assume that you have the real TB disease?
External Actions
12. (If unmarried) Do you feel that even after your condition is cured, it might still make it difficult for you to
marry? (If married) If you were unmarried, do you feel that this condition would have made it difficult for
you to marry, even after it was cured?
13. Do you feel others have avoided or might avoid you because of this problem?
14. Would some people refuse to visit your home because of this condition even after you have been treated?
15. Have you been asked to stay away from work or social groups, or are you concerned that if people knew
about it, that you might be asked to stay away even after treatment?
16. Might you decide on your own to stay away from work or social groups?
17. (If unmarried) If you were married, do you think your spouse might refuse sex with you because of the
problem? (If married) Has your spouse refused sex or might refuse sex with you because of the problem?
18. (If unmarried) If you were married, do you feel that this condition would cause other problems in your
marriage even after it was cured? (If married) Do you feel that even after it is cured, that this condition will
create other problems in your marriage?
19. Now that you have this problem, do you think that your parents and siblings (or children)/parental family will
provide or have provided adequate support?
20. Should your parents and siblings (or children)/parental family have done more to help you?
Courtesy Stigma
21. Might contact with you have any bad effects on others around you even after you have been treated?
22. (If patient has children) Do you feel that your condition might cause social problems for your children in the
community? (If no children) If you had children, do you feel that your condition might cause social problems
for them in the community?
23. Do you feel that this disease might make it more difficult for someone else in your family to marry?
Haitian Identity
24. Is it more embarrassing for you to have a TB-related condition because you are Haitian than it would be for
other people in Florida?
25. Because you are Haitian will people think worse of you than others with the same TB condition?
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Table 2. Demographic Characteristics of Patients

Female
Palm Beach
Broward
Marital status:
Single
Married/partnered
Divorced/widowed
Employment
Full-time
Part-time
Unemployed
Religion
Protestant
Catholic
Other
Literacy (yes)
Interview in Creole
Education
8 yrs or less
9-11 years
12 years
 12 years
Missing

N

%

54
27
63

60.0
30.0
70.0

31
53
6

33.3
58.9
6.7

46
21
22

51.1
23.3
24.4

49
27
14
79
86

54.4
30.0
15.6
87.8
95.6

18
20
19
23
10

20.0
22.2
21.1
25.5
11.1

Given that LTBI is a condition diagnosed in the
absence of symptoms, it is not surprising that a
majority of these patients (61.1%) reported that they
experienced no forms of distress associated with the
disease.
When the no-distress patients were
compared on stigma scores with those who reported
some form of distress (physical, psychosocial,
economic, medication side effects), a significantly
lower mean stigma score was found (20.5 vs. 32.2, p
= .003).
Table 3 presents stigma scores in relation to
referral source - that is, how a patient came to be
diagnosed with LTBI, including contacts of active
TB cases, HIV co-infection, work screening, school
screening, refugee clinic, recent arrival and other
sources. The highest mean stigma score was found
among contacts of cases (31.2), and the lowest score
was found among patients screened for employment
(14.2). Stigma scores for patients in each category
were compared to all others. Contacts of TB cases
had higher stigma scores compared to all others (31.2
vs. 23.3), although this difference had borderline
statistical significance (p = .059).
Table 4 presents stigma scores by patients’
understanding of their condition (“How would you
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describe the condition for which you are being
treated?”). About half the patients identified the “TB
germ,” the local term for LTBI in Haitian Creole.
About 10% each identified the BCG vaccine, denied
having any condition, or did not know. About 5%
said they had TB disease. Patients who rejected the
diagnosis of a medical condition had the highest
mean stigma score (32.7), while those who correctly
identified the TB germ had the lowest (22.7). Due to
the small sample sizes and large variances across
categories these differences were not statistically
significant. It is noteworthy that patients who
correctly identified the nature of their condition (“TB
germ”), and those who identified the BCG vaccine,
which is closely associated with “TB germ” in this
population, there was markedly greater consistency in
stigma scores, as reflected in lower variances.
Significant differences were found in patient
stigma scores by county. The mean score for
Broward County was significantly higher (29.3) than
that for Palm Beach County (15.1) (t=5.2, df = 84, p
< .0001).
Comparison of socio-demographic
characteristics by county showed no differences in
gender, education, income, or employment status,
however patients from Palm Beach County on
average had resided in the U.S. longer, were older,
and proportionately more were widowed and
Protestant. None of the latter socio-demographic
differences were associated with stigma scores or
adherence rate.
Closer examination of the defaulted patients was
conducted based on their interviews and medical
records, including demographic profile, illness
history, responses to key questions, and narrative
commentary provided to selected questions. It is
interesting that all of the defaulters indicated that
they intended to complete therapy when interviewed
near the beginning of their treatment. Like other
LTBI patients, they identified a variety of possible
causes of their conditions, including in rank order
diet, malnutrition, airborne exposure, constitutional
weakness, water, physical exertion, humoral
imbalance, BCG vaccine, germs/infection/contagion,
sanitation, sexual contact, and a hard life, indicating
that there is limited understanding of the ways in
which people acquire latent TB, and the difference
between latent and active TB.
Discussion
Overall low levels of stigma were associated
with latent TB infection in this population, however
strong reluctance to disclose one’s condition to
others, including family members, was found.
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Table 3. Stigma Scores by Referral Source
Referral source*

Frequency (%)

Stigma score

t-test vs. all others

Contact of case

20 (22.2)

31.2

.058

HIV co-infection

7 (7.8)

26.1

NS

Work screening

3 (3.3)

14.2

NS

School screening

3 (3.3)

30.0

NS

Refugee clinic

32 (3.3)

22.1

NS

Recent arrival

3 (3.3)

30.0

NS

Other referral

13 (14.4)

22.8

NS

*Missing = 9

Table 4. Stigma Scores by Patient Description of Condition
LTBI description by patient

N (%)

Mean stigma

SD

TB germ

50 (55.6)

22.7

10.4

BCG vaccine

9 (10.0)

23.5

7.4

Reject diagnosis

9 (10.0)

32.7

21.8

Don’t know/not told

10 (11.1)

26.7

23.8

TB disease

5 (5.6)

29.8

34.4

Other

7 (7.8)

28.1

24.4

Moreover, the findings do not support an association
between patient-perceived stigma and completion of
therapy for LTBI. Therapy completion was not
associated with treatment facility, socio-demographic
characteristics, referral source, participation in
DOPT, perceived cause, or patient understanding of
the condition. There was some evidence that
completion was higher among HIV co-infected
patients, but small sample size in the defaulter group
limits interpretation of this finding.
The rates of therapy for LTBI completion found
in this study were notably higher than what has been
reported for other populations as well as in a previous
statewide study of Florida’s Haitian population
(Lauzardo, Duncan, Szwed, Narita, & Hale, 2001).
Florida Public Health Review, 2010; 7:32-38.
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Self-selection bias may have excluded patients most
likely to default. Only patients who had begun
therapy were included in the study, eliminating
patients who refused treatment altogether. It is
possible that patients who felt the most stigma related
to their diagnosis, and were therefore more likely to
default, were excluded from the study. Refusers often
denied having any TB related condition, and did not
want to have anything to do with a study of
tuberculosis. In addition, study participants were
recruited during the first month of treatment, and
there is evidence that adherence during the first
month of treatment is predictive of therapy
completion (Menzies et al., 2005). However, therapy
completion rates did not differ by county, despite
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differences in refusal rate and stigma scores, as
discussed further below.
Perceived stigma was higher among patients
reporting some form of distress associated with
LTBI, and among defaulters categorized as “lost to
follow-up.” Contacts of cases and patients who
misunderstood the nature of their diagnosis scored
higher on stigma, although not statistically
significant. Nevertheless, it is noteworthy that 44%
of participants did not have a good understanding
about the nature of the condition, including 11% who
said they didn’t know what they had or were not told
anything about the condition.
The higher stigma scores found among patients
in Broward County compared to Palm Beach County
may be attributed to at least two factors, the high
refusal rate in Palm Beach County for participation in
the study, and differences in county TB Programs.
The refusal rate was 60% in Palm Beach County but
only 15% in Broward County. It is possible that
refusers felt greater stigma related to their diagnoses
and therefore the Palm Beach participants were selfselected for lower stigma. Programmatic differences
between counties also may have influenced
differences in perceived stigma as well as participant
recruitment. The main difference between counties is
the organization of their Tuberculosis Programs.
Broward County, for a variety of reasons had been
able to garner more resources for their TB Program at
the time of the study, and was therefore able to
implement a higher level of supervision of LTBI
patients, including more patients on DOT, than is the
standard of care around the US. The more intense
interaction with patients in Broward may have
influenced the presence of higher stigma scores as
well as the higher rate of participation in the study.
This is consistent with other studies which report
higher perceived stigma among patients treated in
closely monitored TB treatment programs (Weiss,
Auer, Somma, & Abouihia, 2006).
Research on the association between close
supervision of therapy of LTBI and adherence is
inconsistent.
Some studies have found higher
completion rates among patients receiving DOPT
(White, Gournis, Kawamura, Menendez, & Tulsky,
2003), while others have found the reverse (Matelli et
al., 2000). Our study did not show an association
between level of patient monitoring and treatment
adherence.
A limitation of the study was the small sample
size of the defaulter patient group (N=18), which
precluded multivariate analysis of results. Bivariate
analyses suggested that differences in stigma scores
within subgroups of defaulters, such as by referral
source and understanding of the condition, warrant
further investigation in relation to therapy
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completion. Stigma reduction among patients is
itself an important clinical goal, and our findings
suggest that patients who report illness-related
distress and patients who are lost to follow up
perceive higher illness-related stigma. Results also
highlight the need for effective patient counseling
strategies to improve patient understanding of the
causes and clinical aspects of latent TB infection, and
to help patients make decisions about disclosure of
the diagnosis to others (Ito, 2004). The findings
underscore the importance of a patient-centered
approach to stigma reduction, which focuses on
influencing intrapersonal factors of the illness
experience (Heijnders & Van Der Meij, 2006). In
particular, early assessment of residential instability,
patient comprehension and concerns about their
diagnosis should be addressed in case management.
Conclusion
No association was found between perceived
stigma and adherence to preventive therapy for LTBI
in this study of Haitian origin patients in South
Florida. There was some evidence that closer clinical
supervision of LTBI patients increased perceptions of
stigma in patients, but this did not affect therapy
completion. The findings are consistent with previous
studies which have been unable to identify clear
predictors of therapy for LTBI completion. Perceived
stigma was associated with patient report of illnessrelated distress, and was higher among patients who
were lost to follow up. The implications for clinical
practice are that patient-centered approaches to
education and counseling about LTBI should focus
on patient understanding of the condition and
concerns about its physical and psychosocial effects.
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